GlobalData on MSN5h
FDA declines to approve Zealand Pharma’s hypoglycaemia therapy in infants
The regulator sought additional analyses from existing continuous glucose monitoring data collected during Phase III trials.
The Daily Northwestern12hOpinion
LTE: The Daily should report the facts without bias, not SJP propaganda
Dear Daily Northwestern Editorial Board, I have just finished reading your news report on Sunday night’s Students for Justice ...
The Item12h
Letter to the editor: Laughing too much to reply to recent letter
I have been asked if I was going to reply to a recent letter to the editor: Don't try to change who a good leader is. I told ...
Denmark's Zealand provides US FDA update on drug for low blood sugar in infants
Denmark's Zealand Pharma said on Tuesday the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) relating to its drug for preventing and treating low blood sugar in ...
Zealand Pharma Gets FDA Complete Response Letter for Hypoglycemia New Drug Application
Zealand Pharma said it has received a complete response letter from the Food and Drug Administration related to its new drug application for dasiglucagon for the prevention and treatment of ...